Premium subscription content, to sign up, join here
It wasn’t long ago that “microdosing” was meant as a way of keeping a drug-induced high throughout the day, but as legal options have become readily available, day-long mood manipulation has become safer, easier, and more attractive.
And if there were ever a year for this kind of consumer behavior to take off, 2020 certainly fits the bill. Aside from cannabis or alcohol, CBD products are offering a variety of new ways to manage how you feel. Gallup reported last year that 14% of Americans use CBD in some form, with the highest percentage of respondents citing its use for pain (40%) followed by anxiety (20%), and as a sleep aid (11%). Stress was noted by 5% of survey respondents. Part of CBD’s rapid rise is because of its ubiquitousness, with products scattered across grocery, convenience, and private stores. Another side of success is the broad assumption of CBD acting as a sort of catch-all solution for aches and wariness of the mind.
Depending on who you ask, CBD is perfect to treat inflammation, anxiety, depression, or even cancer. And whether it has some placebo effect or not is irrelevant, as people are spending their money on it as part of their “share of buzz” that might also include mind-altering options like cannabis or alcohol. Sign up to read more.
This article is part of the Sightlines Premium channel. Only subscribers have access to the content, and the community discussion.
Introducing a premium content subscription with weekly articles, insights, and data that stimulate an ongoing conversation for brewers and beverage producers in emerging categories. Led by Michael Kiser and Bryan Roth of Good Beer Hunting, and a team of category experts, the goal is turn curiosity into actionable insights for business leaders and decision-makers.